MAYZENT

MAYZENT® is the first and only oral medication proven to delay disability progression in individuals with RMS (relapsing multiple sclerosis). My art director partner and I were tasked with developing creative ways to launch this product to the HCP community. Here are some of the best ideas we developed for the launch.

mayzent_splash_Alexa.png
mayzent_CHANGE_12_21.png
mayzent_splash_traffic.png